We also confirmed the characteristic genetic alterations in breast cancer, including missense mutations or amplifications in PIK3CA (4/11 patients), missense mutations or deletions in TP53 (5/11 patients) and amplifications in ERBB2 (4/11 patients; Supplementary Fig. 1)20, 21, 22. Here, PIK3CA is linked to breast cancer.